-
-
-
-
-
-
-
ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
-
-
-
-
-
-
ADMA Biologics Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Possibly Recover Losses
-
-
-
-
-
-
-
ADMA Biologics disputes short-seller report claims
-
-
-
-
-
-
-
ADMA Biologics (ADMA) Reports In-Line Q3 EPS, provides guidance
-
-
-
-
-
-
-
ADMA Biologics (ADMA) PT Raised to $32 at Mizuho
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on ADMA Biologics (ADMA)
-
-
-
-
-
-
-
ADMA Biologics (ADMA) PT Raised to $18 at H.C. Wainwright
-
418,385 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

